sponsored
PatientsVille.com Logo

PatientsVille

Abilify and Ciprofloxacin

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectAbilifyCiprofloxacin
WEIGHT INCREASED3.9% 0%
OFF LABEL USE3.8% 0.8%
DRUG INEFFECTIVE3% 1.8%
NAUSEA1.7% 2.7%
DIARRHOEA0.8% 2.7%
FATIGUE1.8% 2.5%
PAIN1.3% 2.5%
ANXIETY2.4% 1.9%
ARTHRALGIA0.5% 2.4%
PYREXIA0.7% 2.3%
DEPRESSION2.1% 1.3%
DRUG INTERACTION1.4% 2%
INSOMNIA2% 1.2%
DYSPNOEA1% 2%
SUICIDAL IDEATION2% 0%
VOMITING1.3% 1.9%
DIZZINESS1.5% 1.8%
HEADACHE1.4% 1.8%
TREMOR1.8% 0.8%
PAIN IN EXTREMITY0.5% 1.8%
DRUG HYPERSENSITIVITY0% 1.8%
ASTHENIA0.8% 1.7%
SUICIDE ATTEMPT1.7% 0%
TARDIVE DYSKINESIA1.6% 0%
RASH0.7% 1.5%
PNEUMONIA0.6% 1.5%
SOMNOLENCE1.5% 0.5%
PRODUCT USE IN UNAPPROVED INDICATION1.5% 0%
DIABETES MELLITUS1.5% 0%
PSYCHOTIC DISORDER1.5% 0%
MALAISE1.1% 1.4%
ACUTE KIDNEY INJURY0% 1.4%
CONDITION AGGRAVATED1.3% 0.9%
AKATHISIA1.3% 0%
ABDOMINAL PAIN0% 1.3%
MYALGIA0% 1.3%
PARAESTHESIA0% 1.3%
URINARY TRACT INFECTION0% 1.3%
NEUROPATHY PERIPHERAL0% 1.2%
TENDONITIS0% 1.2%
AGITATION1.2% 0%
FEELING ABNORMAL1.1% 0.7%
PRURITUS0% 1.1%
RENAL FAILURE0% 1.1%
ANAEMIA0% 1.1%
HYPOAESTHESIA0% 1.1%
BACK PAIN0% 1.1%
DYSKINESIA1.1% 0%
GAMBLING DISORDER1.1% 0%
MATERNAL EXPOSURE DURING PREGNANCY1.1% 0%
FALL1% 0.9%
CONFUSIONAL STATE1% 0.9%
WEIGHT DECREASED0.8% 1%
INJURY1% 0.7%
GAIT DISTURBANCE0.7% 1%
HYPOTENSION0.5% 1%
DECREASED APPETITE0.5% 1%
OBSESSIVE-COMPULSIVE DISORDER1% 0%
SEPSIS0% 1%
RESTLESSNESS1% 0%
TYPE 2 DIABETES MELLITUS1% 0%
AGGRESSION1% 0%
DEATH0.9% 0.9%
MUSCLE SPASMS0.7% 0.9%
EMOTIONAL DISTRESS0.9% 0.4%
MENTAL DISORDER0.9% 0%
RENAL FAILURE ACUTE0% 0.9%
MUSCULAR WEAKNESS0% 0.9%
THROMBOCYTOPENIA0% 0.9%
TENDON PAIN0% 0.9%
DRUG DOSE OMISSION0.9% 0%
MANIA0.9% 0%
ECONOMIC PROBLEM0.9% 0%
EXTRAPYRAMIDAL DISORDER0.9% 0%
CONSTIPATION0.6% 0.8%
CHEST PAIN0.6% 0.8%
HALLUCINATION0.8% 0%
TREATMENT NONCOMPLIANCE0.8% 0%
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS0.8% 0%
NEUROLEPTIC MALIGNANT SYNDROME0.8% 0%
HOSPITALISATION0.8% 0%
COUGH0% 0.8%
OVERDOSE0.8% 0%
ADVERSE EVENT0.8% 0%
DEHYDRATION0% 0.8%
NEUTROPENIA0% 0.8%
PALPITATIONS0% 0.8%
TENDON RUPTURE0% 0.8%
ABNORMAL BEHAVIOUR0.8% 0%
HYPERTENSION0.7% 0.7%
VISION BLURRED0.7% 0.5%
FEBRILE NEUTROPENIA0% 0.7%
ERYTHEMA0% 0.7%
ABDOMINAL PAIN UPPER0% 0.7%
OEDEMA PERIPHERAL0% 0.7%
CHRONIC KIDNEY DISEASE0% 0.7%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.7%
SCHIZOPHRENIA0.7% 0%
INTENTIONAL OVERDOSE0.7% 0%
DYSTONIA0.7% 0%
FOETAL EXPOSURE DURING PREGNANCY0.7% 0%
BLOOD GLUCOSE INCREASED0.7% 0%
DELUSION0.7% 0%
DISABILITY0.7% 0%
HYPERHIDROSIS0.6% 0.5%
TACHYCARDIA0.5% 0.6%
PULMONARY EMBOLISM0.5% 0.6%
DYSPHAGIA0.6% 0.4%
WRONG TECHNIQUE IN DRUG USAGE PROCESS0.6% 0%
MUSCULOSKELETAL PAIN0% 0.6%
HYPERSENSITIVITY0% 0.6%
HAEMOGLOBIN DECREASED0% 0.6%
CHILLS0% 0.6%
BURNING SENSATION0% 0.6%
URTICARIA0% 0.6%
ATRIAL FIBRILLATION0% 0.6%
TINNITUS0% 0.6%
SEDATION0.6% 0%
COMPLETED SUICIDE0.6% 0%
IRRITABILITY0.6% 0%
HALLUCINATION, AUDITORY0.6% 0%
RESPIRATORY FAILURE0% 0.6%
OBESITY0.6% 0%
PRODUCT USE ISSUE0.6% 0%
COMPULSIVE SHOPPING0.6% 0%
LOSS OF CONSCIOUSNESS0.6% 0%
BLOOD CHOLESTEROL INCREASED0.6% 0%
MEMORY IMPAIRMENT0.6% 0%
MUSCULOSKELETAL STIFFNESS0.5% 0.5%
TOXICITY TO VARIOUS AGENTS0.5% 0.5%
BALANCE DISORDER0% 0.5%
SEPTIC SHOCK0% 0.5%
SYNCOPE0% 0.5%
JOINT SWELLING0% 0.5%
BLOOD CREATININE INCREASED0% 0.5%
TOXIC EPIDERMAL NECROLYSIS0% 0.5%
ALANINE AMINOTRANSFERASE INCREASED0% 0.5%
PLATELET COUNT DECREASED0% 0.5%
TENDON DISORDER0% 0.5%
PLEURAL EFFUSION0% 0.5%
DEEP VEIN THROMBOSIS0% 0.5%
PANCREATITIS0.5% 0%
RENAL IMPAIRMENT0% 0.5%
INFECTION0% 0.5%
ALOPECIA0% 0.5%
VISUAL IMPAIRMENT0% 0.5%
PANCYTOPENIA0% 0.5%
CONVULSION0.5% 0%
PARKINSONISM0.5% 0%
BLOOD CREATINE PHOSPHOKINASE INCREASED0.5% 0%
SEIZURE0.5% 0%
ELECTROCARDIOGRAM QT PROLONGED0.5% 0%
DISTURBANCE IN ATTENTION0.5% 0%
EATING DISORDER0.5% 0%
ABDOMINAL DISCOMFORT0% 0.4%

New treatments are found every day. View current Abilify research studies and Ciprofloxacin clinical trials

1